Aprepitant comprises a (2S)-configured pyrrolidine ring tethered to a 2,4,5-trifluorobenzyl moiety via a 4-oxobutyl linker, with an amide bond connecting to a 3,4-dichlorophenyl group. The structure incorporates three trifluoromethyl substituents, a pyrrolidine heterocycle, and an amide linkage, enhancing metabolic stability and receptor binding affinity. As the parent API, it retains the complete structural configuration necessary for neurokinin-1 receptor antagonism. Serves as an HPLC reference standard for API purity analysis in pharmaceutical formulations.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| EP | Y0001825 โ | 150 MG | EUR 90.00 |
| USP | 1041904 โ | 150 mg | USD 381.00 |
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F
InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1
ATALOFNDEOCMKK-OITMNORJSA-N